PIN1 and breast cancer: Additionally, in tamoxifen-resistant breast cancer, elevated levels of Pin1 enhance its interaction with p-MEK1/2, resulting in increased E2F-4- and Egr-1-driven LC-3 expression (Namgoong et al., 2010).